Quick answer: Yes. Procter & Gamble has agreed to acquire Thorne, the premium supplement company known for practitioner-focused vitamins and wellness products, for approximately $3.8 billion. The deal was announced August 4, 2026, and is expected to close in fiscal 2027 if regulatory and other customary closing conditions are satisfied.
For people who have followed the natural supplement industry for years, this is a significant development. Thorne built its reputation as a science-focused, premium supplement company with an emphasis on quality, testing and practitioner relationships. P&G, on the other hand, is one of the world’s largest consumer-products companies, with brands ranging from Tide and Dawn to Pampers, Gillette, Oral-B, Vicks and numerous other household and personal-care products.
So what happens when a company like Thorne becomes part of a company like Procter & Gamble?And perhaps more importantly, what does this say about the future of independent natural supplement companies?
Why Is Procter & Gamble Buying Thorne?
P&G says the acquisition is intended to strengthen its health-care portfolio and give the company a stronger position in the growing market for self-care, prevention and personalized wellness. That is a logical business decision.
Thorne has spent years building credibility in a premium segment of the supplement industry. Its products are marketed around scientific research, quality and practitioner trust. P&G already has a substantial health-care business that includes brands such as Oral-B, Vicks, Metamucil, Pepto-Bismol and other personal health products.
Adding Thorne gives P&G an established premium wellness brand instead of having to build one from scratch.
The price is substantial: approximately $3.8 billion. P&G’s SEC filing confirms that it entered into the agreement on August 4, 2026, and expects the transaction to close during the second quarter of fiscal 2027, subject to regulatory approval and customary closing conditions.
At the time of this writing, therefore, Thorne has not yet become a P&G-owned company. It has entered into an agreement to be acquired.
Dwindling Market Share of Independent Operations
Life Not Labs has been pressing its own capsules here in Upstate New York since the spring of 2015. Over the past 11+ years, I have seen countless small operations go under or get bought out—usually the former. Since the Thorne buyout, I have been contacted twice by people interested in acquiring this website. Life Not Labs has no plans to sell. Vitamin companies driven by a commitment to supplying people with real ingredients are far too rare in 2026.
These buyouts are making it increasingly difficult for consumers to find quality products. As I wrote about in a blog post last year, some supplement companies are spending up to eight times as much on advertising as they do on their ingredients. This leaves consumers with lower-quality products as more money is directed toward advertising, graphic design, and printing.
We are one of the few operations that does not spend money on advertising. We rely solely on organic web traffic and word of mouth from our customers. Any money spent on advertising takes away from our ability to provide high-quality ingredients. As we move further into an age of multibillion-dollar operations dominating the supplement world, only an informed customer base can help ensure that natural, independent vitamin producers can survive. Shop local, but also make sure your products are coming from operations that use third party tested superfood extracts and natural ingredients instead of chemicals and fillers.
What Happens to the Thorne Brand?
This is probably the question most Thorne customers are asking. The answer is that we don’t know everything yet.
P&G has publicly emphasized that it sees Thorne’s quality, scientific credibility and practitioner relationships as important assets. P&G’s announcement specifically describes Thorne as a science-driven wellness company with high-quality supplements and personalized health solutions. That suggests P&G has no immediate reason to destroy the characteristics that made Thorne valuable in the first place.
In fact, the opposite may be true.
When a large corporation spends billions of dollars acquiring a premium brand, it generally wants the brand’s existing reputation to continue producing value. But ownership changes the long-term equation.
Once an independent company becomes part of a multinational corporation, decisions about ingredients, manufacturing, suppliers, packaging, distribution, pricing, marketing and margins ultimately exist within a much larger corporate structure.
That does not automatically mean that Thorne’s products will become worse. It does mean that Thorne is no longer an independent company making decisions independently of a multinational consumer-products corporation. That distinction rightly matters to many consumers.
Thorne Has Been Here Before
Interestingly, this isn’t the first time Thorne has been acquired.
Thorne merged with Onegevity in 2021 and became part of Thorne HealthTech. Then, in 2023, Thorne HealthTech was acquired by investment firm L Catterton in a transaction valued at approximately $680 million, with shareholders receiving $10.20 per share in cash. Thorne subsequently became a privately held company.
Now, only about three years later, that business is being sold again — this time to Procter & Gamble for approximately $3.8 billion. That is a remarkable increase in transaction value. It also illustrates something important about the supplement industry:
Successful natural-health brands have become extremely valuable acquisition targets.
Why Does This Matter to People Who Buy Natural Vitamins?
There is nothing inherently wrong with a company growing, attracting investment or eventually selling.
But there is a philosophical difference between building a supplement company around the quality of ingredients and building a corporation around maximizing the value of a portfolio of brands.
Those objectives can overlap. They can also conflict.
A small supplement company might ask:
Is this the best ingredient we can put into the product?
A large corporation may have to ask a much longer list of questions:
What does the ingredient cost?
Can we purchase it in sufficient volume?
Can we manufacture it more efficiently?
Can we improve the margin?
Can we simplify the supply chain?
Can we increase distribution?
Can we sell more units?
Those are legitimate business questions. But they are different questions from the ones that originally motivated many small natural-product companies.
This Is Where Life Not Labs Is Different
Life Not Labs has been making vitamins and plant-based supplements since 2015. We’re a very different type of operation from Thorne — and certainly from Procter & Gamble.
We’re a small, independent company based in Upstate New York. We make our own products in small batches, and many of the decisions we make begin with the ingredient rather than the potential profit margin.
I have been approached about buying the company and am not interested. This isn’t because I believe every large company is bad, or because selling a business is inherently wrong. Building a company and eventually selling it can be a perfectly legitimate business decision. For me, however, there is a point where the purpose of the company changes.
If Life Not Labs were sold to a massive conglomerate whose primary responsibility is to its shareholders, I would have to accept that decisions about the company would eventually be made according to priorities that are different from ours.
We want Life Not Labs to remain a company where the quality of the ingredients matters more than how many units we can sell.
We Are Part of a Dwindling Group
The natural supplement industry has changed dramatically since we started. There are now more supplement brands than ever.
But having a natural-looking label is not the same thing as being an independent natural supplement company.
Today, a brand can be created without ever owning a manufacturing operation. Formulas can be developed, packaged and shipped through third-party manufacturers, while the brand owner concentrates primarily on advertising and sales. That will never be our model
We belong to a shrinking group of supplement companies that were built around making products, rather than simply building a brand around products made elsewhere.
What About Procter & Gamble?
This is where it is worth looking beyond the fact that P&G owns household names. Procter & Gamble is enormous.
During fiscal 2026, P&G reported approximately $84 billion in net sales and $16.1 billion in net earnings. The company also returned more than $15 billion to shareholders through dividends and share repurchases.
Its portfolio includes products in beauty, grooming, oral care, personal health care, laundry, cleaning, baby care, feminine care and household paper products.
P&G is therefore not a natural vitamin company that happened to become large. It is a global consumer-products conglomerate that is adding a premium supplement company to its health-care portfolio. That is a very different starting point.
P&G Makes Chemicals, Too
Another important distinction is that P&G’s business extends well beyond finished consumer products.
P&G Chemicals is a global producer and marketer of fatty alcohols, fatty acids, methyl esters and glycerin. These materials are used in applications including personal care, household and industrial cleaning, agrochemicals, pharmaceuticals and other industries.
P&G describes these products as bio-based and says many are made from responsibly sourced natural feedstocks. That is worth acknowledging.
The purpose here is not to suggest that everything P&G makes is toxic or environmentally harmful. It isn’t. The point is that the scale and nature of P&G’s business are fundamentally different from a small company making organic and plant-based supplements in small batches.
P&G operates chemical manufacturing and supplies ingredients to other industries around the world. It also operates massive consumer-product businesses involving detergents, cleaners, fragrances, personal-care products, plastics and other materials.
That is the kind of corporate diversity you would expect from one of the world’s largest consumer-products companies. It is simply a long way from a small natural vitamin operation.
P&G’s Carbon Footprint Is on a Completely Different Scale
The difference becomes especially obvious when looking at environmental impact.
P&G reports that its fiscal 2025 Scope 1 and Scope 2 greenhouse-gas emissions totaled approximately 2.079 million metric tons of CO₂ equivalent. Scope 1 covers direct emissions from operations, while Scope 2 covers purchased energy.
But that isn’t the whole footprint.
P&G estimates its fiscal 2024/25 Scope 3 emissions at approximately:
- 13.7 million metric tons from purchased goods and services
- 3.4 million metric tons from upstream transportation and distribution
- 152.5 million metric tons from use of sold products
- 8.3 million metric tons from end-of-life treatment of sold products
- Approximately 92,000 metric tons from business travel
That means the company’s reported Scope 3 categories alone amount to roughly 178 million metric tons of CO₂ equivalent when those reported categories are added together. P&G notes that approximately 98% of its Scope 3 emissions come from four major categories. That 178 million metric tons of CO₂ means P & G has a larger carbon footprint than 175 of the 207 countries listed on Worldometers– Including countries such as the Netherlands, Columbia and Bangladesh, a country with 180 million people living in it.
P&G is also working to reduce these emissions and has established a goal of net-zero greenhouse-gas emissions across its operations and supply chain by 2040. The company reports that its Scope 1 and 2 emissions have already fallen 61% from its 2010 baseline. So this is not a simple story of “P&G has a huge carbon footprint and does nothing about it.” P&G clearly has sustainability programs and emissions-reduction targets.
Does the P&G Acquisition Mean Thorne Is No Longer a Natural Company?
That is a question consumers will have to answer for themselves. Thorne products do not automatically become lower quality because P&G owns the company.
P&G has explicitly said that Thorne’s scientific credibility, product quality and practitioner relationships are part of what made the company attractive in the first place.
The more meaningful question is whether those characteristics remain central to the company years from now.
- Will Thorne continue to make the same ingredient choices?
- Will its manufacturing philosophy remain the same?
- Will its supply chain remain the same?
- Will its formulas change?
- Will its prices change?
- Will the company remain as independent in its decision-making?
Those are questions that cannot yet be answered. The acquisition is simply too recent.
There Is Still a Place for Independent Supplement Companies
There is still an important place for small, independent supplement companies in an industry that is increasingly dominated by large corporations and investment groups. The reason is simple: scale is not always an advantage when the goal is to make products with carefully selected ingredients, small production runs, and as much oversight as possible from the people responsible for the finished product.
Small operations can make decisions that are difficult to justify in a mass-market business model. An unusual plant extract, a more expensive food-based ingredient, or an ingredient sourced from a smaller domestic supplier may not make financial sense when a company is producing millions of units. For a small manufacturer, however, the decision can be based more directly on whether the ingredient belongs in the formula and whether it provides something worthwhile to the customer.
Maximum Oversight by Small Vitamin Operations
Small-batch production also creates a different level of oversight. When products are made in relatively small quantities, there is an opportunity to pay close attention to the ingredients going into each batch, the manufacturing process, the finished product, and the packaging. The people making the product can remain much closer to the process. That doesn’t automatically make a small company better, and large manufacturers can have excellent quality-control systems, but there is something valuable about keeping production close to the people who developed the product and are accountable for it.
The same principle applies to fillers and unnecessary ingredients. Consumers increasingly want to know exactly what they are putting into their bodies. A small operation may be more willing to build a formula around the active ingredient itself rather than adding ingredients simply because they make manufacturing easier, extend shelf life, improve appearance, or reduce production costs. When the emphasis is on the nutritional value of the product, there is less reason to add anything that does not serve a clear purpose.
This is especially important with plant-based and food-derived supplements. Ingredients such as algae, herbs, mushrooms, fruit extracts, fermented foods, and other botanical sources can be more complicated or expensive to work with than standardized commodity ingredients. Yet those differences are often exactly what consumers are looking for when they choose a natural supplement. A small manufacturer has the flexibility to pursue those ingredients without having to justify every decision against the enormous volume requirements of a multinational corporation.
Accountability: Access To The Decision Maker in Creating Vitamins
There is also the question of accountability. When a supplement company is small enough that the people behind the products are directly involved in sourcing, formulation, manufacturing, and customer service, there are fewer layers between the customer and the person making the decisions. A customer can ask where an ingredient came from, why it was selected, how a product is made, or what goes into a particular formula and potentially receive an answer directly from someone who actually knows.
As more independent supplement brands are acquired by larger companies, that kind of independence becomes harder to find. Acquisitions do not automatically mean that a product will become lower quality, and large companies are certainly capable of producing safe and effective supplements. But consolidation can reduce the number of companies whose entire business model is built around making relatively small quantities of products with carefully chosen ingredients.
That is why small supplement manufacturers still matter. They provide consumers with another choice: products made on a smaller scale, with greater flexibility in ingredient selection, closer oversight, fewer unnecessary ingredients, and a direct connection to the people responsible for making them. In an industry where bigger is increasingly becoming the norm, keeping some of the smaller operations alive gives consumers the ability to choose something different.
Thorne’s Acquisition Is a Sign of the Times
The $3.8 billion Thorne acquisition is more than a corporate transaction. It is another sign that the natural-health and supplement industry has become valuable enough that the world’s largest corporations want a piece of it.
For consumers, that makes it more important than ever to look beyond the front of the bottle.
- Ask who actually makes the product.
- Ask where the ingredients come from.
- Ask whether the company is independently owned.
- Ask whether the people behind the brand would make the same decisions if they were not accountable to investors expecting continued growth.
And if independence matters to you, support independent companies while they are still independent.
At Life Not Labs, we intend to stay that way.
We’ve been making our own vitamins since 2015, and we’ve turned down opportunities to sell because we believe there is value in remaining small, independent and focused on the quality of what goes into our products.
There may be fewer companies like that every year. We intend to remain one of them.
